Thunen Shelley B's Form 4 filing
RxSight, Inc. (RXST) · filed Apr 2, 2024
- Accession no.
- 0000950170-24-040174
- Filed
- Apr 2, 2024
- Trade date
- Apr 1, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 0 derivative transactions. Open-market sales total $997.9K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Thunen Shelley BCIK 0001297491 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 1, 2024 | Common Stock | SSaleDisposed | −8,857 | $49.81 | −$441,167.17 | 19,545 | Indirect | |
| Apr 1, 2024 | Common Stock | SSaleDisposed | −800 | $50.27 | −$40,216 | 18,745 | Indirect | |
| Apr 1, 2024 | Common Stock | SSaleDisposed | −8,938 | $49.81 | −$445,201.78 | 9,807 | Indirect | |
| Apr 1, 2024 | Common Stock | SSaleDisposed | −662 | $50.24 | −$33,258.88 | 9,145 | Indirect | |
| Apr 1, 2024 | Common Stock | SSaleDisposed | −200 | $50.37 | −$10,074 | 8,945 | Indirect | |
| Apr 1, 2024 | Common Stock | SSaleDisposed | −543 | $51.50 | −$27,964.5 | 8,402 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.